Andrew Zullo, PharmD, PhD, ScM

Andrew Zullo, PharmD, PhD, ScM

Clinical Pharmacy Specialist, Research

Andrew R. Zullo, PharmD, PhD, focuses on improving medication and vaccine use for older adults. In particular, he aims to optimize medication and vaccine use for the outcomes of greatest importance to older adults, such as physical and cognitive function. Zullo conducts research in geriatric pharmacoepidemiology and health services research. He specializes in studying the functional outcomes of medication use in institutional post-acute care and long-term care. He often applies pharmacoepidemiologic, comparative effectiveness and safety, and causal inference methodologies to large administrative claims, electronic health record, and other linked datasets that provide information on older adults. Andrew's work occasionally also includes medication-related evidence synthesis projects. Zullo is also an associate professor at Brown University. Learn more about Zullo's research on the Brown University website.

Education: Rutgers University (PharmD, 2012); Brown University School of Public Health (PhD, 2017); Brown University School of Public Health (MS, 2015)

Residencies: PGY-1, Patient-Centered Outcomes Research Postdoctoral Fellowship, Center for Evidence Synthesis in Health, Brown University School of Public Health; PGY-2, Health Services Research Postdoctoral Fellowship, Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center

Practice/Research Interests: Pharmacoepidemiology, causal inference, geriatrics

Select Publications: 

Riester MR, Goyal P, Jiang L, Erqou S, Rudolph JL, McGeary JE, Rogus-Pulia NM, Madrigal C, Quach L, Wu WC, Zullo AR. New Antipsychotic Prescribing Continued into Skilled Nursing Facilities Following a Heart Failure Hospitalization: a Retrospective Cohort Study. J Gen Intern Med. 2022 Jan 3. doi: 10.1007/s11606-021-07233-2. Epub ahead of print. PMID: 34981366.

McConeghy KW, Cinque M, White EM, Feifer RA, Blackman C, Mor V, Gravenstein S, Zullo AR. Lessons for deprescribing from a nonessential medication hold policy in US nursing homes. J Am Geriatr Soc. 2022 Feb;70(2):429-438. doi: 10.1111/jgs.17512. Epub 2021 Oct 25. PMID: 34695233; PMCID: PMC8821115.

Zullo AR, Duprey MS, Smith RJ, Gutman R, Berry SD, Munshi MN, Dore DD. Effects of dipeptidyl peptidase-4 inhibitors and sulphonylureas on cognitive and physical function in nursing home residents. Diabetes Obes Metab. 2022 Feb;24(2):247-256. doi: 10.1111/dom.14573. Epub 2021 Oct 27. PMID: 34647409; PMCID: PMC8741644.